European Commission opened an investigation to decide whether Vitor Pharma had abused its dominance by spreading misleading information regarding the safety of its closest competitor Pharmacosmos’s Monofer medicine used for intravenous iron treatment. The press release dated 20.06.2022 about the investigation is available via https://ec.europa.eu/commission/presscorner/detail/en/ip_22_3882